LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,155 Cr | ₹2,007 Cr | ₹1,663 Cr | ₹1,580 Cr | ₹1,354 Cr |
What is the latest Sundry Debtors ratio of LAURUS LABS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹2,155 Cr |
| Mar2025 | ₹2,007 Cr |
| Mar2024 | ₹1,663 Cr |
| Mar2023 | ₹1,580 Cr |
| Mar2022 | ₹1,354 Cr |
How is Sundry Debtors of LAURUS LABS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,155 Cr | 7.37 | |
| Mar2025 | ₹2,007 Cr | 20.70 | |
| Mar2024 | ₹1,663 Cr | 5.22 | |
| Mar2023 | ₹1,580 Cr | 16.71 | |
| Mar2022 | ₹1,354 Cr | - | |
Compare Sundry Debtors of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹111,247.8 Cr | -0.6% | 8% | 130.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -0.6% |
8% |
130.4% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses